1 / 13

Polycystic ovaries at ultrasound: normal variant or silent polycystic ovary syndrome?

UOG Journal Club: August 2012. Polycystic ovaries at ultrasound: normal variant or silent polycystic ovary syndrome?. S. Catteau-Jonard, J. Bancquart, E. Poncelet, C. Lefebvre-Maunoury, G. Robin, D. Dewailly Volume 40 Issue 2, Date: August 2012, pages 223–229.

cathleen-lang
Download Presentation

Polycystic ovaries at ultrasound: normal variant or silent polycystic ovary syndrome?

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. UOG Journal Club: August 2012 Polycystic ovaries at ultrasound: normal variant or silent polycystic ovary syndrome? S. Catteau-Jonard, J. Bancquart, E. Poncelet, C. Lefebvre-Maunoury, G. Robin, D. Dewailly Volume 40 Issue 2, Date: August 2012, pages 223–229 Journal Club slides prepared by Ligita Jokubkiene (UOG Editor for Trainees)

  2. Polycystic ovary syndrome (PCOS) is the most common cause of: • Hyperandrogenism • Infertility • Anovulation • Affects 5–10 % of women of reproductive age Norman RJ M et al., Lancet 2007

  3. Rotterdam criteria for PCOS* • 12 or more follicles 2–9 mm in size in at least one ovary, or ovarian volume >10 mL at ultrasound examination on cycle day 2–5 • Oligo- and/or anovulation • Clinical and/or biochemical signs of hyperandrogenism *At least two of the three criteria are necessary for PCOS diagnosis Revised 2003 consensus. Hum Reprod 2004

  4. Polycystic ovaries (PCO) Only ultrasound criteria are met: 12 or more follicles 2–9 mm in size in at least one ovaryor ovarian volume >10 mL Observed in 21–63 % of apparently normal women Is PCO a normal ovarian appearance or does it reflect ovarian follicle abnormality in a similar way to PCOS? The inclusion of PCO ultrasound criteria into the PCOS definition is controversial because of lack of specificity. Polson DW et al., Lancet 1988 Farquhar CM et al., Aust N Z J Obstet Gynaecol 1994 Duijkers IJ et al., Gynecol Endocrinol 2010 Johnstone EB et al., J Clin Endocrinol Metab 2010

  5. Polycystic ovaries at ultrasound: normal variant or silent polycystic ovary syndrome? S. Catteau-Jonard et al., UOG 2012 Objective To determine whether PCO is a normal ovarian state or whether it reflects an abnormality in ovarian folliculogenesis similar to PCOS

  6. Comparative study (2004–2008) Three age-matchedgroups of 95 women in each group: Control group – no symptoms and normal ovaries at ultrasound PCO group – no symptoms but PCO at ultrasound* PCOS group – PCOS according to Rotterdam criteria* • Comparison of: • Hormonal parameters • Metabolic parameters • Ultrasound parameters • Exclusion criteria: • Women with at leastone follicle >9 mm • Serum estradiol level > 300 pmol/L *Ovarian volume was not considered for PCO and PCOS definition

  7. Methodology • Clinical examination: • Assessment of hirsutism • Measurement of waist circumference • Body mass index (BMI) • Blood pressure • Ultrasound examination: • Menstrual cycleday 2–5 • 2D transvaginal ultrasound • Follicles 2–9 mm counted • Serum sampling: • Estradiol,17-OH-progesterone • Testosterone (elevated if ≥ 0.6ng/mL) • Androstenedione (elevated if ≥ 2.2 ng/mL) • DHEAS, LH, FSH, SHBG, insulin • Anti-Mullerianhormone (AMH) • Free-androgen index, HDL cholesterol, triglycerides DHEAS, dehydroepiandrosterone sulfate; HDL, high-density lipoprotein; LH, luteinizing hormone: FSH, follicle-stimulating hormone; SHBG, sex-hormone-binding globulin

  8. Statistical analysis Follicle number = Right ovary + Left ovary Ovarian area = Right ovary + Left ovary ANOVA and covariance analysis with Bonferroni correction on log values

  9. Number of follicles 2–9 mm and AMH serum level * p<0.05 Number of follicles and AMH level is intermediate in women with PCO: significantly higher than in controls and significantlylower than in PCOS group. Difference in AMH remains significant after adjustment for follicle 2–9 mm number

  10. Comparison of AMH serum levels • Subgroups of PCOS women: • Amenorrhea (Am) – no menstrual periods > 3 months (n = 13) • Oligomenorrhea (Oligo) – < 8 menstrual periods in preceding year (n = 70) • Eumenorrhea (Eum) – regular menstrual cycle 25 – 35 days (n = 12) AMH level was similar between women with PCO and eumenorrheic women with PCOS. Both groups had significantly lower AMH levels than PCOS patients with oligomenorrhea and amenorrhea.

  11. Hormonal parameters Controls PCO PCOS P-value Testosterone 1.39 (0.17–3.57) 0.79 (0.17–1.84) 0.90 (0.14–1.80) < 0.05* Andro- stenedione 4.37 (0.63–7.66) 5.25 (1.57–7.70) 6.09 (2.1–17.36) < 0.05* Androgen serum levelsexcept for DHEAS were similar between control and PCO groups and significantlyhigher in PCOS group than in PCO group. LH was significantlyhigher in PCOS group than PCO group. No difference in FSH and estradiol levels between PCOS and PCO groups was observed. *Difference between PCO and PCOS groups; results presented as median (range)

  12. Metabolic parameters No difference in any metabolic markers (BMI, blood pressure, waist circumference, insulin, triglycerides, SHBG, HDL cholesterol) between control and PCO groups BMI, waistcircumference and triglyceridessignificantlyhigher in women with PCOS than control or PCO group SHBG, HDL cholesterol levelssignificantlylower in PCOS than control or PCO group

  13. Polycystic ovaries at ultrasound: normal variant or silent polycystic ovary syndrome? S. Catteau-Jonard et al., UOG 2012 • Conclusions • PCO is an abnormal condition that differs from controls by higher AMH serum levels but not by hyperandrogenism. This suggests a granulosa cell abnormality in PCO similar to that observed in PCOS • The absence of hyperandrogenism in PCO does not seem to be linked to the metabolic status

More Related